Cargando…

Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases

Colorectal cancer is characterized by an increase in the utilization of glucose and a diminishment in the oxidation of butyrate, which is a short chain fatty acid. In colorectal cancer cells, butyrate inhibits histone deacetylases to increase the expression of genes that slow the cell cycle and indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Anna, Bennett, Natalie, Ahmed, Bettaieb, Whelan, Jay, Donohoe, Dallas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007476/ https://www.ncbi.nlm.nih.gov/pubmed/29930765 http://dx.doi.org/10.18632/oncotarget.25546

Ejemplares similares

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Inhibition of Histone Deacetylase by Butyrate Protects Rat Liver from Ischemic Reperfusion Injury
por: Sun, Jie, et al.
Publicado: (2014)

Pyruvate kinase M1 regulates butyrate metabolism in cancerous colonocytes
por: Park, Bohye, et al.
Publicado: (2022)

Zyflamend, a unique herbal blend, induces cell death and inhibits adipogenesis through the coordinated regulation of PKA and JNK
por: Puckett, Dexter, et al.
Publicado: (2020)

Butyrate inhibits Staphylococcus aureus-aggravated dermal IL-33 expression and skin inflammation through histone deacetylase inhibition
por: Luo, Chia-Hui, et al.
Publicado: (2023)

Sodium Butyrate Stimulates Expression of Fibroblast Growth Factor 21 in Liver by Inhibition of Histone Deacetylase 3
por: Li, Huating, et al.
Publicado: (2012)

Butyrate potentiates Enterococcus faecalis lipoteichoic acid-induced inflammasome activation via histone deacetylase inhibition
por: Park, Ok-Jin, et al.
Publicado: (2023)

Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
por: Chen, Yiming, et al.
Publicado: (2021)

Butyrate upregulates endogenous host defense peptides to enhance disease resistance in piglets via histone deacetylase inhibition
por: Xiong, Haitao, et al.
Publicado: (2016)

Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
por: Ni, Yun-Feng, et al.
Publicado: (2010)

The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging
por: Walsh, Michael E., et al.
Publicado: (2015)

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
por: Flatmark, Kjersti, et al.
Publicado: (2006)

Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties
por: MacDonald, Amber F., et al.
Publicado: (2018)

Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway
por: Puckett, Dexter L., et al.
Publicado: (2020)

Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress
por: Mercado, Nicolas, et al.
Publicado: (2011)

Microbial Oncotarget: Bacterial-Produced Butyrate, Chemoprevention and Warburg Effect
por: Donohoe, Dallas R., et al.
Publicado: (2013)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia
por: Jaworska, Joanna, et al.
Publicado: (2017)

Histone Deacetylases and Their Inhibition in Candida Species
por: Garnaud, Cécile, et al.
Publicado: (2016)

Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
por: Alzoubi, Samer, et al.
Publicado: (2016)

CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells
por: Lazarova, Darina L, et al.
Publicado: (2013)

The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats
por: Park, Min Jung, et al.
Publicado: (2016)

Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule
por: Chriett, Sabrina, et al.
Publicado: (2019)

Butyrate and Class I Histone Deacetylase Inhibitors Promote Differentiation of Neonatal Porcine Islet Cells into Beta Cells
por: Zhang, Yichen, et al.
Publicado: (2021)

Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid
por: Yuille, Samantha, et al.
Publicado: (2018)

Sodium butyrate facilitates CRHR2 expression to alleviate HPA axis hyperactivity in autism-like rats induced by prenatal lipopolysaccharides through histone deacetylase inhibition
por: Wang, Xinyuan, et al.
Publicado: (2023)

Histone Deacetylase Inhibitor, Sodium Butyrate-Induced Metabolic Modulation in Platycodon grandiflorus Roots Enhances Anti-Melanogenic Properties
por: Ahn, Min-A, et al.
Publicado: (2023)

Pseudophosphatase MK-STYX Alters Histone Deacetylase 6 Cytoplasmic Localization, Decreases Its Phosphorylation, and Increases Detyrosination of Tubulin
por: Cao, Yuming, et al.
Publicado: (2019)

Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD
por: Chen, Yanwei, et al.
Publicado: (2012)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood–Brain Barrier After Stroke
por: Lu, Hui, et al.
Publicado: (2022)

Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells
por: Biermann, Julia, et al.
Publicado: (2011)

Sodium Butyrate, a Histone Deacetylase Inhibitor, Exhibits Neuroprotective/Neurogenic Effects in a Rat Model of Neonatal Hypoxia-Ischemia
por: Ziemka-Nalecz, Malgorzata, et al.
Publicado: (2016)

Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas
por: Tang, Zijiao, et al.
Publicado: (2023)

Histone deacetylase inhibition leads to neuroprotection through regulation on glial function
por: Wu, Xuefei, et al.
Publicado: (2013)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma
por: Guo, Shan-qi, et al.
Publicado: (2012)

Preventing ototoxic hearing loss by inhibiting histone deacetylases
por: Layman, W S, et al.
Publicado: (2015)

Targeted inhibition of histone deacetylase 6 in inflammatory diseases
por: Ran, Jie, et al.
Publicado: (2019)

Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
por: Klingl, Yvonne E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4mm0t74hb13thgbtahf85gidtl